Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Opdivo

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Opdivo was produced by Gilead Sciences.

Encouraging signs in biomarker R&D

Encouraging signs in biomarker R&D In June 2018, Bristol Myers-Squibb sought approval for Opdivo and low-dose Yervoy in lung cancer in patients with a TMB of greater than ten mutations per megabase. ... impact of Opdivo plus Yervoy on OS in first-line NSCLC patients’.

Third strike for BMS’ Opdivo in brain cancer

Third strike for BMS’ Opdivo in brain cancer Despite failing first endpoint, trial is set to continue. Bristol-Myers Squibb’s (BMS) immuno-oncology blockbuster Opdivo has failed a third straight clinical trial in the hard-to-treat brain ... Opdivo plus standard first-line temozolomide and

Roche scores EU approval twice for Tecentriq in lung cancer

Roche scores EU approval twice for Tecentriq in lung cancer Bristol-Myers Squibb is also testing its own PD-1 inhibitor Opdivo (nivolumab) in this indication, with a trial currently in phase 2.

MSD’s Keytruda catches up in kidney cancer

MSD’s Keytruda catches up in kidney cancer This is an improvement on BMS’ rival therapy Opdivo, which won its approval on the back of the phase 3 CheckMate-214 clinical trial in January.This trial showed that Opdivo ... It also has another advantage over Opdivo, having been approved

Celgene boosts IO presence with Immatics deal

Celgene boosts IO presence with Immatics deal These candidates are among the most promising in Celgene’s portfolio, and once the merger is complete, with create a formidable oncology franchise, adding to BMS' checkpoint inhibitor blockbuster Opdivo. ... BMS/Celgene know they must build their

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics